For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Nootropic / Cognitive

PE-22-28

Also known as: PE 22-28

PE-22-28 is a 7-amino-acid synthetic analog of spadin, a peptide fragment (residues 22-28) of the 44-aa propeptide (PE) released during post-translational maturation of sortilin (the neurotensin receptor-3). It is studied in preclinical models as a fast-acting antidepressant that works by selectively blocking the TREK-1 two-pore potassium channel. There is no established use for hair growth — that is a separate compound and the two should not be confused.

Real-time market data

Pricing for PE-22-28

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Average price

$5.78/mg

range $3.46–$9.00/mg

Sellers

21

from $40.00

45-day trend

+3.7%

vs 45-day avg $/mg

17 of 21 sellers have a current price· 12 stale listings hidden (not seen in 7 days)

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Independent evidence

COAs for PE-22-28

15 third-party tests across 7 vendors. Each card links to the full report.

All 15 COAs for PE-22-28 →
Measured purity 99.0%–99.8% across 11 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.77 %
May 2026
ILS Labs Strong

For

PE-22-28

by Ion Peptide· batch PE228-05202026

✓ Vendor-published
99.77 %
May 2026
ILS Laboratories

For

PE-22-28

by Ion Peptide· batch PE228-05202026

COA on file
Aggregated · 3rd-party listing
99.46 %
May 2026
Freedom Diagnostics Moderate

For

Pe-22-28

by Real Peptides· batch Black Cap

Aggregated · 3rd-party listing
99.49 %
Jan 2026
Freedom Diagnostics Moderate

For

PE-22-28

by Kimera Chems· batch KC-P28-YEL1

Aggregated · 3rd-party listing
99.32 %
Jan 2026
Janoshik Analytical Limited · HPLC

For

PE-22-28

by Peptidegurus· batch Jan 12nd 2026

Aggregated · 3rd-party listing
98.99 %
Dec 2025
Chromate Moderate

For

PE-22-28

by Orbitrex Peptides· batch PE22101225

Aggregated · 3rd-party listing
99.69 %
Nov 2025
Vanguard Laboratory Strong

For

PE-22-28

by Peptidology· batch 1666

✓ Vendor-published
99.22 %
Nov 2025
RUO

For

PE-22-28

by Ruo Bio· batch PE2001

COA on file
Aggregated · 3rd-party listing
99.48 %
Oct 2025
MZ Biolabs Moderate · HPLC

For

PE-22-28

by Ascension Peptides· batch 41-06250728

Aggregated · 3rd-party listing
99.48 %
Oct 2025
MZ Biolabs Moderate · HPLC

For

PE-22-28

by Ascension Peptides· batch 41-06250728

Aggregated · 3rd-party listing
99.52 %
May 2025
Janoshik Analytical Limited · HPLC

For

PE-22-28

by Skye Peptides· batch PE25-08-001

Aggregated · 3rd-party listing
99.72 %
Freedom Diagnostics Moderate

For

PE-22-28

by Peptide Plugs· batch 129-01-SM

Aggregated · 3rd-party listing
Dec 2025

Purity not on file

BioRegen Moderate

For

PE-22-28

by Real Peptides

Aggregated · 3rd-party listing
Oct 2025

Purity not on file

Janoshik Analytical Limited

For

PE-22-28

by Skye Peptides· batch PE25-10-001

✓ Vendor-published

Purity not on file

Lab unknown

For

PE-22-28

by Ruo Bio

COA on file
Research depth

6 citations indexed for PE-22-28

All research on PE-22-28 →

rct · 2025

Effects of multivitamin combined with magnesium sulfate versus magnesium sulfate alone on hemodynamics, coagulation, and maternal-infant outcomes in preeclampsia: a randomized controlled study

Objective To explore the effects of multivitamin combined with magnesium sulfate on placental hemodynamics, coagulation function, and maternal and infant outcomes in preeclampsia patients.

review · 2023

Interventional Mental Health: A Transdisciplinary Approach to Novel Psychiatric Care Delivery

Mental health disorders are among the most common health conditions in the United States. Traditional clinical treatments rely on psychiatric counseling and, in many cases, prescription medications.

review · 2020

Enabling pregnant women and their physicians to make informed medication decisions using artificial intelligence

The role of artificial intelligence (AI) in healthcare for pregnant women. To assess the role of AI in women's health, discover gaps, and discuss the future of AI in maternal health. A systematic review of English articles using EMBASE, PubMed, and SCOPUS. Search terms included pregnancy and AI.

Study · 2020

Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany

Background Studies have reported seasonal variations regarding the incidence and the short-term mortality of pulmonary embolism (PE). The aim of this study was to identify sex-specific and age-related differences in seasonal patterns regarding hospitalisations and mortality of PE patients.

review · 2019

Role of TREK-1 in Health and Disease, Focus on the Central Nervous System

TREK-1 is the most studied background K 2P channel. Its main role is to control cell excitability and maintain the membrane potential below the threshold of depolarization.

animal · 2017

Shortened Spadin Analogs Display Better TREK-1 Inhibition, <i>In Vivo</i> Stability and Antidepressant Activity

Depression is a devastating mental disorder that affects 20% of the population worldwide. Despite their proven efficacy, antidepressants present a delayed onset of action and serious adverse effects. Seven years ago, we described spadin (PE 12-28) as a promising endogenous peptide with antidepressant activity.